NEWTON, Mass.--(BUSINESS WIRE)--Cheetah Medical, a rapidly growing medical device company, announced today that it has appointed Douglas M. Hansell, MD, MPH, Assistant Clinical Professor of Anesthesia at Massachusetts General Hospital, as Chief Physician Executive, effective Nov. 17, 2014. Dr. Hansell will succeed William T. (“Pepper”) Denman, M.D., also a Massachusetts General Hospital physician, who has served in a part-time consulting role as Cheetah Medical’s Chief Medical Officer for nearly two years.
“It is with great pleasure that I announce that Dr. Doug Hansell will be joining Cheetah Medical as our Chief Physician Executive next week,” said Chris Hutchison, President and CEO of Cheetah Medical. Dr. Hansell comes to us from GE Healthcare, where he has been Chief Medical Officer since 2010. During his tenure at GE Dr. Hansell established and led a global medical affairs organization supporting the broad diagnostic GE portfolio including diagnostic imaging, monitoring, healthcare IT, life sciences and GE Partners and GE Joint Ventures. Dr. Hansell also led the centralization of all global clinical research and the establishment of a global clinical research organization.
“Before joining GE, Dr. Hansell served as Chief Medical Officer for the Respiratory and Monitoring division of Covidien. He also has extensive experience working in early-stage organizations and thus brings a rich and relevant background to us at Cheetah. I have known Doug since 2009 and am delighted to have the chance to work with him again. I know he will make huge contributions as we work to make Stroke Volume the next Vital Sign,” said Mr. Hutchison.
“I want to thank Dr. Pepper Denman, who has been a great resource to Cheetah since starting with us in April 2013,” added Mr. Hutchison.
Dr. Hansell will continue to maintain his clinical duties as an Anesthesiologist at Massachusetts General Hospital.
The Company’s FDA-cleared and CE-marked CHEETAH NICOM™ System is used for non-invasive hemodynamic monitoring during perioperative fluid assessment of patients in the Critical Care or Surgery settings. The CHEETAH NICOM is the only completely noninvasive product designed to provide real-time, continuous, and dynamic monitoring of IV fluids that has been predicated against the previous ‘gold standard’ of Pulmonary Artery Catheter (PAC).
About Cheetah Medical
Headquartered in Newton, Mass., and approved in 60 countries including the U.S., Cheetah Medical is a rapidly growing medical device company with a breakthrough technology, CHEETAH NICOM™, designed to set a new standard of care for noninvasive, beat-to-beat, user- and patient-friendly cardiac output monitoring. CHEETAH NICOM has met with success in patients undergoing Guided Fluid Therapy during surgery, in critical care patients who are being fluid resuscitated to manage sepsis, and in trauma patients who have experienced high fluid loss. To learn more, please visit www.cheetah-medical.com